ACER THERAPEUTICS INC.: cash_and_equivalents

Value{"amount": 2329218, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2022-12-31)
Statuscurrent
EntityACER THERAPEUTICS INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-23-009992 · Open the official SEC filing →
Retrieved: 2026-08-19T10:35:24.233006+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001069308/cash-and-equivalents/2022-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/190b5b7f-9eac-4658-a620-941cb392a3bd

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies